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Cardiac pacing is a proven therapy of cardiac conduction disturbances
and an effective treatment modality in many cardiac arrhythmias.
Implantable cardiac defibrillators (ICDs) are particularly beneficial for select-
ed groups of patients with a history of severe ventricular arrhythmias or
at a high risk of sudden cardiac death. Despite their potential lifesaving
properties, both pacemakers and ICDs are associated with a number of
complications. The most frequent include pneumothorax; myocardial per-
foration; lead malposition, displacement or fracture due to excessive manip-
ulation of the device by the patient (Twiddler’s syndrome) [1]. Another
group of complications comprises infections: from the pacemaker pocket
to bacterial endocarditis with its origin on leads or the tricuspid valve, fail-
ure of leads to pace and/or sense appropriately, erosion of the pacemak-
er site or its leads, and thrombotic events with the most frequently
observed subclavian vein thrombosis [2]. In the era of massive anticoag-
ulation and antiplatelet therapy bleeding complications are not uncom-
mon, either.
The rate of acute complications from device implantation is acceptable
and ranges from 3% to 7% [1-3], depending on the patient group. Never-
theless the problem seems important when account is taken of the fact
that permanent devices are implanted in over 250,000 patients a year in
the United States alone.
The paper entitled "Heart perforation in patients with permanent car-
diac pacing - personal observations" presents cases of lead perforation
treated in a single medical centre, with well-described diagnostic and treat-
ment procedures. Results of this paper are largely consistent with litera-
ture findings, but there nevertheless are some interesting differences, as
outlined below [4]. Studies have reported overall lead perforation rates
after pacemaker implantation to be 0.1-0.8%, and after ICD placement -
0.6-5.2% [3]. The highest reported rate of perforation, based on autopsy,
was 27% for patients with atrial leads [5]. Authors of the present paper
report a very low incidence rate (0.09%), which is probably related to the
engagement of a highly experienced medical team [4]. There are no uni-
form classifications accounting for the complication. It may be acute (devel-
oping during the first 24 h after implantation), subacute (up to 1 month)
or chronic. Another classification system divides perforations into early
(occurring during the first month after placement) and late. In the pres-
ent paper, the authors report on cases of subacute and delayed lead per-
forations. Most of them (5/6 patients) were symptomatic, but in all of
them pacing or sensing failure was present [4].
Excessive loop or tension on the lead will predispose to a forward move-
ment through the thinner right atrial or ventricular wall, particularly the apex.
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Copyright © 2012 Termedia & BanachOther contributing factors may be the growing
prevalence of thinner, dilated cardiac chambers with
impaired systolic function as well as recent episode
of myocardial infarction. Five out of 6 presented
patients suffered from coronary heart disease [4].
It would be very interesting to establish whether
they had an episode of myocardial infarction in the
past and, if so, to know its precise location. As com-
monly known, a higher risk of lead perforation is
observed in patients with inferior wall or right ven-
tricular myocardial infarction. The fact that atrial
perforations were more common type than ven-
tricular is not surprising. The right atrial wall is very
thin, averaging only 2 mm in thickness, while the
right ventricular wall is twice as thick [6]. Therefore
logically one would anticipate a higher risk of 
atrial wall perforation. In contrast to that pattern,
however, five out of six diagnosed perforations
reported in this paper involved the right ventricu-
lar wall [4].
Symptoms, signs and changes of pacing param-
eters depend on the location of the lead tip. It can
be located in the pericardium, mediastinum, pleu-
ral space, lung, chest muscles and even in the
abdomen. Consequently, the most commonly
observed symptoms include chest pain, dyspnoea,
syncope, abdominal pain, muscle or diaphragm
stimulation and hiccups. The haemodynamic sta-
tus depends predominantly on the development of
pericardial effusion. Cardiac tamponade leads to
hypotension, shock or even cardiac arrest, and
requires lifesaving intervention, usually open-chest
surgery. Perforated electrodes also frequently lead
to pacing and sensing failures. In general, the cap-
ture threshold will be increased, whereas the sens-
ing threshold will be reduced. Inappropriate ICD
shocks are also observed.
The most frequently reported predictors of lead
perforation are temporary leads, steroid use, active
fixation leads, low body mass index (< 20 kg/m2),
older age, female gender and concomitant antico-
agulation therapy [7, 8]. Temporary leads are typi-
cally stiffer than permanent leads, thus elevating
the risk of myocardial perforation especially in the
case of recent or acute myocardial infarction. Lead
type may also increase the risk of perforation: it
occurs more frequently with atrial leads, active fix-
ation systems, ICD leads, leads with a small diam-
eter or a small tip surface – as well as excessive
length of the electrode [9]. Perforations occur more
frequently in the right ventricular apex which is
thinner than the intraventricular septum or the out-
flow tract [10-12]. In contrary to these general data,
however, the authors noted only one case of per-
forated right ventricular apex and as many as 6 cas-
es of perforated right ventricular outflow tract [5].
The only known protective factor for cardiac perfo-
ration is right ventricular systolic pressure > 35 mm
Hg. Decreased incidence rate may be due to coex-
isting right ventricular hypertrophy [13]. The inci-
dence of cardiac muscle perforation by ICD leads is
associated with the number of delivered shocks [14].
Patients with the above symptoms should be
investigated to evaluate the risk of lead perfora-
tion. Pacemaker system interrogation, echocardio-
graphy, chest radiography and computed tomogra-
phy (CT) scanning can be very helpful to either
prove or rule out the complication. Capture and
sensing threshold values should be compared
against previous results. Although inappropriate
pacemaker function may indicate a possibility of
perforation or intracardiac leads migration, normal
pacemaker function does not exclude the compli-
cation. Crucial for the diagnosis of perforation is
visualization of the lead and its tip. Chest X-ray is
a technique used to compare the lead tip position
and lead curvature with previous results. The diag-
nosis of perforation is certain if the lead is outside
the cardiac silhouette. It can also be helpful to eval-
uate extracardiac complications such as pleural or
pericardial effusion and pneumothorax. Transtho-
racic echocardiography is a very simple, bedside tool
which makes it possible to assess electrode loca-
tion. It is sufficient for proving diagnosis in most
cases and very helpful for monitoring pericardial
effusion dynamics. Computed tomography scan
proves very valuable when echocardiography and
X-ray test are not diagnostic. Consequently, CT scan
is currently a gold standard in the diagnosis of lead
perforations [15], even though the technique also
has its limitations. The star artifact is a well-known
artifact related to the imaging of metal implants.
Surrounding the electrode tip, it sometimes makes
it difficult to precisely identify the lead tip.
Late perforations are often asymptomatic and
characterized by a very low rate of cardiac tam-
ponade or death [16]. The finding of a late perfora-
tion may represent an asymptomatic acute perfo-
ration or a true late perforation.
Because the right heart is a low-pressure sys-
tem, a perforation may be sealed by a combination
of muscle contraction and fibrosis over the lead,
resulting in no sequelae. The rate of unrecognized
asymptomatic perforations is much higher than
symptomatic and riches 15% [6]. In these cases the
lead impedance and pacing thresholds did not dif-
fer between patients with and without lead perfo-
ration. In a small perforation, dislocation of the lead
may be very small, so the cathode may be close to
the epicardium and the anode within the endo-
cardium, resulting in proper pacemaker function. It
thus follows that normal impedance and pacing
parameters do not exclude the presence of a per-
foration. On the other hand, elevated pacing thresh-
olds may indicate a perforation. Similarly to symp-
tomatic perforations, in asymptomatic cases atrial
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leads perforate more frequently than ventricular
ones, and ICD leads perforate more frequently than
ventricular pacemaker leads.
Patient management strategy should depend on
the dynamics of symptoms, pericardial effusion and
haemodynamic status. In the case of haemody-
namic instability, rapid progression of pericardial
effusion, surgical management (open chest surgery)
seems to be the best treatment option. In other
cases, in stable conditions, simple direct traction
with or without percutaneous dilators can be con-
sidered, though under close echocardiographic
monitoring and with a surgical backup. Lead extrac-
tion should be followed by new lead placement in
a different location, preferably in the right ventric-
ular outflow tract or the intraventricular septum. In
the case of open-chest surgery the implantation of
epicardial leads should be considered. During the
postprocedural period, closed haemodynamic and
echocardiographic monitoring is mandatory
because delayed re-tamponade could develop
(especially when the surgeon could not identify the
location of cardiac muscle perforation) [12]. In cas-
es of acute or subacute lead perforation the implan-
tation of a new pacemaker might be unnecessary.
Appropriate management of asymptomatic lead
perforation is a debated issue. Some studies sug-
gest that the diagnosis of lead perforation neces-
sitates lead removal [3]. Results of other studies [6],
however, suggest that the extraction of a chroni-
cally perforated lead without malfunctioning of the
device is not mandatory. In addition, the risk of car-
diac tamponade should be considered after the
removal of chronically implanted leads. Another fact
worth considering is that a significant number of
those leads are partially perforated.
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